Published in Aust Vet J on April 01, 2010
Proactive Management of the Equine Athlete. Animals (Basel) (2012) 0.75
Isohemagglutinins of graft origin after ABO-unmatched liver transplantation. N Engl J Med (1984) 2.25
Analysis of the growth of recombination-deficient strains of Escherichia coli K-12. J Bacteriol (1974) 1.82
Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection (2009) 1.64
Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol (1988) 1.45
Implementation of the Patient Self-Determination Act (PSDA) in nursing homes in New York City. J Am Geriatr Soc (1997) 1.43
In vivo cross-match by chromium-51 urinary excretion from labeled erythrocytes: a case of anti-Gerbich. J Nucl Med (1990) 1.42
Strategies for the review of transfusion practices. JAMA (1989) 1.15
Repeatability of subjective evaluation of lameness in horses. Equine Vet J (2010) 1.14
The definition of ABO factors in transplantation: relation to other humoral antibody states. Transplant Proc (1987) 1.13
Equine laminitis: membrane type matrix metalloproteinase-1 (MMP-14) is involved in acute phase onset. Equine Vet J (2008) 1.10
Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. J Natl Cancer Inst (1995) 1.08
Use of C-reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well-baby nursery. Pediatrics (2000) 1.06
A normal aPTT does not guarantee adequate coagulation factor levels. Anesthesiology (2001) 0.96
Variation in the use of red blood cell transfusions. A study of four common medical and surgical conditions. Med Care (1995) 0.93
Blastocystis subtypes in symptomatic and asymptomatic family members and pets and response to therapy. Intern Med J (2012) 0.93
Anti-Rho(D) in two Rh-positive patients receiving kidney grafts from an Rh-immunized donor. Transplantation (1986) 0.91
Antibody mediated rejection of human liver allografts: transplantation across ABO blood group barriers. Transplant Proc (1989) 0.91
Equine laminitis: loss of hemidesmosomes in hoof secondary epidermal lamellae correlates to dose in an oligofructose induction model: an ultrastructural study. Equine Vet J (2004) 0.90
Monitoring distances travelled by horses using GPS tracking collars. Aust Vet J (2010) 0.90
Distances travelled by feral horses in 'outback' Australia. Equine Vet J Suppl (2010) 0.90
Histopathology of oligofructose-induced acute laminitis in heifers. J Dairy Sci (2005) 0.89
Age-related features of the resting and P300 auditory evoked responses using the dipole localization method and cortical imaging technique. J Neurosci Methods (1990) 0.89
Changes in equine hindgut bacterial populations during oligofructose-induced laminitis. Environ Microbiol (2006) 0.89
Red cell alloimmunization in multitransfused HLA-typed patients. Transfusion (1988) 0.88
Equine laminitis: induced by 48 h hyperinsulinaemia in Standardbred horses. Equine Vet J (2010) 0.88
Do preoperative laboratory tests predict blood transfusion needs in cardiac operations? J Thorac Cardiovasc Surg (1983) 0.86
Chronic pyelonephritis in a brood mare. Aust Vet J (1987) 0.84
The effects of freezing skin on transdermal drug penetration kinetics. J Vet Pharmacol Ther (2007) 0.84
Lamellar pro-inflammatory cytokine expression patterns in laminitis at the developmental stage and at the onset of lameness: innate vs. adaptive immune response. Equine Vet J (2007) 0.84
Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis? Equine Vet J Suppl (1998) 0.83
Anti-A production by a group O spleen transplanted to a group A recipient. Vox Sang (1985) 0.83
Nuclear magnetic resonance-based metabonomic study of early time point laminitis in an oligofructose-overload model. Equine Vet J (2011) 0.82
In vitro evidence for a bacterial pathogenesis of equine laminitis. Vet Microbiol (2001) 0.82
Decision-making capacity to execute a health care proxy: development and testing of guidelines. J Am Geriatr Soc (2000) 0.82
Zymographic analysis of equine laminitis. Histochem Cell Biol (1999) 0.82
Thermolysin activates equine lamellar hoof matrix metalloproteinases. J Comp Pathol (2002) 0.81
Physiological responses of horses to a treadmill simulated speed and endurance test in high heat and humidity before and after humid heat acclimation. Equine Vet J (1999) 0.81
Glucose transport in the equine hoof. Equine Vet J (2011) 0.81
Equine laminitis: cleavage of laminin 5 associated with basement membrane dysadhesion. Equine Vet J (2004) 0.81
Novel keratins identified by quantitative proteomic analysis as the major cytoskeletal proteins of equine (Equus caballus) hoof lamellar tissue. J Anim Sci (2010) 0.81
Cryptosporidium in a red-bellied snake (Pseudechis porphyriacus) Aust Vet J (1978) 0.81
Continuous digital hypothermia initiated after the onset of lameness prevents lamellar failure in the oligofructose laminitis model. Equine Vet J (2013) 0.80
Acute bovine laminitis: a new induction model using alimentary oligofructose overload. J Dairy Sci (2004) 0.80
The structure, innervation and location of arteriovenous anastomoses in the equine foot. Equine Vet J (1994) 0.79
A new biomechanical approach to assessing the fragility of the internal elastic lamina of the arterial wall. Connect Tissue Res (1993) 0.79
Simultaneous quantitation of oxidised and reduced glutathione in equine biological fluids by reversed-phase high-performance liquid chromatography using electrochemical detection. J Chromatogr B Biomed Appl (1995) 0.79
Equine laminitis: increased transcription of matrix metalloproteinase-2 (MMP-2) occurs during the developmental phase. Equine Vet J (2004) 0.79
Use of BAER to identify loss of auditory function in older horses. Aust Vet J (2011) 0.79
Equine laminitis induced with oligofructose. Equine Vet J (2006) 0.79
Rehabilitative optometric services for survivors of acquired brain injury. Arch Phys Med Rehabil (1988) 0.79
Hoof and distal limb surface temperature in the normal pony under constant and changing ambient temperatures. Equine Vet J (1992) 0.79
Localisation of gelatinase activity in epidermal hoof lamellae by in situ zymography. Histochem Cell Biol (1998) 0.78
Spatio-temporal progression of the AEP P300 component using the cortical imaging technique. Brain Topogr (1993) 0.78
Equine laminitis: cryotherapy reduces the severity of the acute lesion. Equine Vet J (2004) 0.78
The developmental and acute phases of insulin-induced laminitis involve minimal metalloproteinase activity. Vet Immunol Immunopathol (2011) 0.78
Advanced glycation endproducts in horses with insulin-induced laminitis. Vet Immunol Immunopathol (2011) 0.78
The feral horse foot. Part B: radiographic, gross visual and histopathological parameters of foot health in 100 Australian feral horses. Aust Vet J (2013) 0.78
Equine laminitis model: cryotherapy reduces the severity of lesions evaluated seven days after induction with oligofructose. Equine Vet J (2009) 0.78
Digital hypothermia inhibits early lamellar inflammatory signalling in the oligofructose laminitis model. Equine Vet J (2011) 0.78
The effects of allopurinol on the ultrastructure of ischaemic and reperfused large intestine of sheep. Aust Vet J (1996) 0.78
Equine laminitis: glucose deprivation and MMP activation induce dermo-epidermal separation in vitro. Equine Vet J (2004) 0.78
Equine laminitis: congenital, hemidesmosomal plectin deficiency in a Quarter Horse foal. Equine Vet J (2004) 0.78
Characterisation of the alpha 1-protease inhibitor system in Thoroughbred horse plasma by horizontal two-dimensional (ISO-DALT) electrophoresis. 1. Protein staining. Anim Blood Groups Biochem Genet (1983) 0.78
Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. Transfusion Practices Committee of the American Association of Blood Banks. Ann Thorac Surg (1990) 0.77
Equine laminitis: comparative histopathology 48 hours after experimental induction with insulin or alimentary oligofructose in standardbred horses. J Comp Pathol (2011) 0.77
Adaption of horses to a novel dynamic feeding system: movement and behavioural responses. Equine Vet J (2012) 0.77
Characterisation of the alpha 1-protease inhibitor system in Thoroughbred horse plasma by horizontal two-dimensional (ISO-DALT) electrophoresis. 2. Protease inhibition. Anim Blood Groups Biochem Genet (1983) 0.77
Rhabdomyolysis and pulmonary hypertension in a child, possibly due to long-term high-dose propofol infusion. Intensive Care Med (1996) 0.77
Histopathology of insulin-induced laminitis in ponies. Equine Vet J (2010) 0.77
Equine laminitis: ultrastructural lesions detected in ponies following hyperinsulinaemia. Equine Vet J (2009) 0.77
Recovery from transport and acclimatisation of competition horses in a hot humid environment. Equine Vet J (2001) 0.77
The timeline of lamellar basement membrane changes during equine laminitis development. Equine Vet J (2011) 0.77
CD34(+) cell collection efficiency does not correlate with the pre-leukapheresis hematocrit. Bone Marrow Transplant (2001) 0.77
Complement C5a: impact on the field of veterinary medicine. Vet J (2012) 0.77
The timeline of metalloprotease events during oligofructose induced equine laminitis development. Equine Vet J (2011) 0.77
Physiological responses in nonheat acclimated horses performing treadmill exercise in cool (20 degrees C/40% RH), hot dry (30 degrees C/40% RH) and hot humid (30 degrees C/80% RH) conditions. Equine Vet J Suppl (1996) 0.77
Pharmacokinetics of intravenous, plain oral and enteric-coated oral omeprazole in the horse. J Vet Pharmacol Ther (2014) 0.76
In situ zymography: topographical considerations. J Biochem Biophys Methods (2001) 0.76
The plasma protease inhibitor system (Pi) of Standardbred horses. Anim Blood Groups Biochem Genet (1984) 0.76
The experimental infection of horses with Murray Valley encephalitis and Ross River viruses. Aust Vet J (1987) 0.76
Barazone decreases skin lesions and pruritus and increases quality of life in dogs with atopic dermatitis: a randomized, blinded, placebo-controlled trial. J Vet Pharmacol Ther (2010) 0.76
Blood component recalls in the United States, 1998. Transfusion (2000) 0.76
Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horses. J Vet Pharmacol Ther (2000) 0.76
Histopathological examination of chronic laminitis in Kaimanawa feral horses of New Zealand. N Z Vet J (2012) 0.76
The new age of organic blood banking. Transfusion (1998) 0.75
Detection of cytomegalovirus antibody in stored blood components. Transfusion (1988) 0.75
Frequency of PLA1 in blacks. Transfusion (1986) 0.75
Corneal fibropapillomatosis in green sea turtles (Chelonia mydas) in Australia. J Comp Pathol (2009) 0.75
Illness in horses following spraying with amitraz. Aust Vet J (1984) 0.75
Efficacy of avermectin B1 given orally against equine intestinal strongyles and Onchocera microfilaria. Aust Vet J (1990) 0.75
Subdivision of equine Tf into H1 and H2. Anim Genet (1988) 0.75
The feral horse foot. Part A: observational study of the effect of environment on the morphometrics of the feet of 100 Australian feral horses. Aust Vet J (2012) 0.75